| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-06 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
9e-06 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
8e-05 |
| mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |